CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 251 filers reported holding CYTOKINETICS INC in Q4 2021. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $132,628 | -83.8% | 4,502 | -82.0% | 0.00% | -100.0% |
| Q2 2023 | $816,674 | -88.4% | 25,036 | -87.5% | 0.00% | -91.7% |
| Q1 2023 | $7,035,079 | -20.8% | 199,917 | +3.2% | 0.01% | -20.0% |
| Q4 2022 | $8,878,083 | -4.7% | 193,760 | +0.7% | 0.02% | -6.2% |
| Q3 2022 | $9,319,000 | +27.6% | 192,355 | +3.5% | 0.02% | +33.3% |
| Q2 2022 | $7,303,000 | -8.5% | 185,893 | -14.3% | 0.01% | +20.0% |
| Q1 2022 | $7,985,000 | -19.8% | 216,948 | -0.6% | 0.01% | -9.1% |
| Q4 2021 | $9,951,000 | – | 218,329 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $6,580,834 | 7.72% |
| Finepoint Capital LP | 431,693 | $12,717,676 | 6.33% |
| Saturn V Capital Management LP | 495,168 | $14,587,649 | 6.11% |
| Logos Global Management LP | 1,250,000 | $36,825,000 | 4.91% |
| DAFNA Capital Management LLC | 479,538 | $14,127,189 | 4.39% |
| PFM Health Sciences, LP | 2,399,545 | $70,690,596 | 3.33% |
| Boxer Capital, LLC | 2,100,000 | $61,866,000 | 3.29% |
| Integral Health Asset Management, LLC | 800,000 | $23,568,000 | 3.26% |
| GREAT POINT PARTNERS LLC | 600,000 | $17,676,000 | 3.22% |
| Nicholas Investment Partners, LP | 942,137 | $27,755,356 | 2.07% |